Research Pinpoints Libby Amphibole DiseaseAsbestos Exposure & Bans
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
- Assisting mesothelioma patients and their loved ones since 2006.
- Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
- A+ rating from the Better Business Bureau.
- 5-star reviewed mesothelioma and support organization.
"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."LashawnMesothelioma patient’s daughter
How to Cite Asbestos.com’s Article
Povtak, T. (2021, September 21). Research Pinpoints Libby Amphibole Disease. Asbestos.com. Retrieved February 8, 2023, from https://www.asbestos.com/news/2018/01/04/libby-amphibole-asbestos-disease/
Povtak, Tim. "Research Pinpoints Libby Amphibole Disease." Asbestos.com, 21 Sep 2021, https://www.asbestos.com/news/2018/01/04/libby-amphibole-asbestos-disease/.
Povtak, Tim. "Research Pinpoints Libby Amphibole Disease." Asbestos.com. Last modified September 21, 2021. https://www.asbestos.com/news/2018/01/04/libby-amphibole-asbestos-disease/.
A research team led by thoracic surgeon Dr. Raja Flores has identified Libby amphibole asbestos disease for the first time as the puzzling killer that continues to threaten innocent victims exposed to one variety of asbestos.
This progressive pulmonary disease involves lamellar pleural thickening (LPT) that has a suffocating effect on the lungs.
Diagnostic signals are unusual when compared to more common asbestos-related diseases, making it difficult to identify early by traditional means. The CT and pulmonary function abnormalities look different.
“It’s a process that kills people before cancer does, before lung cancer or mesothelioma,” Flores told Asbestos.com. “It’s a different disease. And it’s killing more of these people than anything else.”
The Journal of Occupational and Environmental Medicine published the research in December. The Centers for Disease Control (CDC) provided a $4.8 million epidemiology research grant to fund it.
“This is a new disease, which is why it was important to publish this paper. It’s the first study to really describe the syndrome of Libby amphibole disease,” Flores said. “It can rapidly progress to death, much quicker than others.”
Subtle Differences Are Important
The disease stems from amphibole asbestos and its needle-shaped fibers. Almost all of it was mined in or near Libby, Montana, where it was mixed with vermiculite — a relatively harmless ingredient by itself — and used for insulation.
The mining there, from 1919 to 1990, led to the longest-running man-made environmental disaster in American history and an asbestos cleanup project by the Environmental Protection Agency (EPA) just now coming to a close.
Hundreds of people — including miners and nearby residents — have died from the asbestos-related disease. Thousands more have been sickened with various illnesses attributed to the mining.
The recent study was done by doctors and scientists from the Mount Sinai Health System and Northwell Health in New York, the University of Montana, Montana State University and the Center for Asbestos Related Disease (CARD) in Libby.
The study focused on former mine workers and contractors who have been part of a CARD program that began in 2000 and included regular monitoring.
Researchers found 87 percent of the miners exposed to Libby amphibole had pleural abnormalities and 68 percent had specific LPT. Flores said Libby amphibole doesn’t lead to the same kind of asbestosis as chrysotile — the more commonly used type of asbestos.
“But it kills you quicker,” he said. “Places endemic with Libby amphibole need to know what to look for. We saw it for years, but never picked up on the subtleties. It was always ‘why did this patient die?’”
Amphibole Asbestos Still Prevalent
The vermiculite and amphibole mix for decades was shipped throughout America for processing and still exists in commercial and residential construction.
“Legacy asbestos still lives throughout the country, in buildings everywhere,” Flores said. “We need to identify areas filled with Libby amphibole and try and prevent further contamination because this is a relentless, progressive killer.”
According to the study, similar amphibole deposits have been found in surface sites in Arizona and Nevada. Some experts believe the increase in asbestos-related diseases among women and younger adults in Southern Nevada may be traced to those sites.
“I wish we could say, we found this, and you can do this to reverse it, and make people better,” Flores said. “But we still don’t have anything. All you can do now is minimize potential exposure, and that includes abatement where we know there is amphibole asbestos.”